MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Staged Bilateral MRI-Guided Focused Ultrasound Thalamotomy in Essential Tremor a Single Institution Experience of 26 Patients

    N. Pertsch, K. Sakakura, YJ. Ahn, D. Kim, J. Mueller, L. Chiu, J. Varela, S. Patel, J. Pearce, N. Patel, S. Sani (Chicago, USA)

    Objective: We describe tremor outcomes, adverse effects, and impact to quality of life after staged bilateral MRI-Guided Focused Ultrasound (MRgFUS) Thalamotomy for Essential Tremor. Background:…
  • 2025 International Congress

    Programming Strategies to Improve Stimulation-Induced Dysgeusia: A Rare-Side Effect In Deep Brain Stimulation For Essential Tremor

    Y. Degirmenci, A. Yilmaz (Istanbul, Turkey)

    Objective: Deep brain stimulation (DBS) targeting ventralis intermedius nucleus (Vim) is a well-known treatment option for medication-refractory tremor in essential tremor (ET). Common stimulation-induced side…
  • 2025 International Congress

    Comparative Efficacy and Safety of VMAT2 Inhibitors for Chorea in Huntington’s Disease: A Systematic Review and Meta-Analysis

    A. Abunamoos, M. Mustafa, F. Alnajjar, Y. Aljazi, K. Moghib, N. Hamam, M. Alghaniem (Amman, Jordan)

    Objective: To assess the safety and efficacy of vesicular monoamine transporter 2 (VMAT2) inhibitors (deutetrabenazine, tetrabenazine, valbenazine) in managing chorea in Huntington’s Disease (HD). Background:…
  • 2025 International Congress

    A Case of “Rabbit” Syndrome with Concomitant Tongue Tremor

    J. Martin, A. Juell, J. Jacobson (San Antonio, USA)

    Objective: N/A Background: “Rabbit” syndrome (RS), also known as oral vertical dyskinesia is a rare movement disorder characterized by involuntary, rhythmic vertical movements, primarily affecting…
  • 2025 International Congress

    Seven-year follow-up of clinical and neurophysiological features in essential tremor

    L. Angelini, S. Grandolfo, D. Birreci, D. Costa, M. de Riggi, A. Martini, S. Aloisio, A. Cannavacciuolo, S. Agkun, G. Paparella, M. Bologna (Pozzilli IS, Italy)

    Objective: To prospectively follow-up a sample of Essential Tremor (ET) patients to identify trends in the progression of motor and cognitive symptoms. Background: ET is…
  • 2025 International Congress

    Prevalence of Essential Tremor in elderly people in Southern Brazil

    C. Sangali, G. Pereira, D. Dos Santos, N. Bruscato, A. Schumacher Schuh, C. Rieder (Porto Alegre, Brazil)

    Objective: To assess the prevalence of Essential Tremor (ET) in elderly individuals from Veranópolis, Rio Grande do Sul, Brazil. Background: ET is one of the…
  • 2025 International Congress

    Efficacy and Safety of Dual-Target Transcranial Magnetic Stimulation in Essential Tremor: A Phase 2 Randomized, Controlled, Patient-Assessor blinded Trial

    J. Xu, N. Cao, Y. Qu, S. Shang, X. Bai, X. Liu, X. Liu, X. Wang, F. Hu, Q. Qu, M. Zhang, H. Cao (Xi’an, China)

    Objective: To investigate the efficacy and safety of transcranial magnetic stimulation (TMS) by combined cortical and cerebellar as dual-target in the treatment of essential tremor…
  • 2025 International Congress

    Safety, Feasibility, and Effects of Time-Restricted Eating in Early-Stage Huntington’s Disease: Preliminary Analysis of a Clinical Pilot Trial

    R. Wells, L. Neilson, A. Hiller (Portland, USA)

    Objective: Evaluate whether 12 weeks of daily time-restricted eating (TRE) appears safe and feasible in persons with early-stage Huntington's disease (HD) and explore its effects…
  • 2025 International Congress

    Efficacy and Safety of Deutetrabenazine in Huntington’s Disease: a Systematic Review

    A. Viapiana, V. Müller, L. Lima, A. Petry, R. Juvêncio, A. Ribeiro, D. Gonçalves, M. da Rosa, G. Maia, V. Xavier (Porto Alegre, Brazil)

    Objective: To evaluate efficacy and safety of deutetrabenazine (DTB) in Huntington's Disease (HD) in order to guide evidence-based clinical decisions. Background: HD is a genetic…
  • 2025 International Congress

    Huntington’s Disease: Overview from 20 Years of a Single-Center Experience

    M. Tsalta-Mladenov, M. Levkova, M. Hachmeriyan, L. Angelova (Varna, Bulgaria)

    Objective: This study evaluates patient data from individuals with Huntington’s disease who attended our single tertiary center. Background: Huntington’s disease is an inherited neurodegenerative disorder…
  • « Previous Page
  • 1
  • …
  • 223
  • 224
  • 225
  • 226
  • 227
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley